EP1455814 - PHARMACEUTICAL COMPOSITIONS COMPRISING UNACYLATED GHRELIN FOR USE IN THE TREATMENT OF INSULIN RESISTANCE [Right-click to bookmark this link] | |||
Former [2004/38] | PHARMACEUTICAL COMPOSITIONS COMPRISING UNACYLATED GHRELIN AND THERAPEUTICAL USES THEREOF | ||
[2011/42] | Status | No opposition filed within time limit Status updated on 08.02.2013 Database last updated on 31.08.2024 | Most recent event Tooltip | 30.05.2014 | Lapse of the patent in a contracting state New state(s): LU | published on 02.07.2014 [2014/27] | Applicant(s) | For all designated states Alizé Pharma SAS 15, Chemin du Saquin Espace Européen 69130 Ecully / FR | [2012/14] |
Former [2009/32] | For all designated states Alizé Pharma SAS 15, Chemin du saquin Espace Européen 69130 Ecully / FR | ||
Former [2007/50] | For all designated states Alizé Pharma SAS 13, Chemin de la Chonchance 69110 Ste-Foy-lès-Lyon / FR | ||
Former [2007/49] | For all designated states Alizé Pharma Inc. 56 Kalvin Avenue Montreal QC H2V 1T3 / CA | ||
Former [2007/48] | For all designated states 6551131 Canada Inc. 56 Kelvin Avenue Montreal QC H2V 1T3 / CA | ||
Former [2006/41] | For all designated states Erasmus MC P.O. Box 2040 3000 CA Rotterdam / NL | ||
Former [2004/38] | For all designated states THERATECHNOLOGIES INC. 2310 boulevard Alfred Nobel Saint-Laurent, Québec H4S 2A4 / CA | Inventor(s) | 01 /
GHIGO, Ezio D'Azeglio 22 10125 Torino / IT | 02 /
VAN DER LELY, Aart Jan Papavertuin 14 NL-2662 CW Bergschenhoek / NL | [2004/38] | Representative(s) | Regimbeau 139, rue Vendôme 69477 Lyon Cedex 06 / FR | [2012/49] |
Former [2012/14] | Tetaz, Franck Claude Edouard, et al Cabinet Regimbeau 139, rue Vendôme 69477 Lyon Cedex 06 / FR | ||
Former [2009/49] | Tetaz, Franck Claude Edouard, et al Cabinet Régimbeau 139, rue Vendôme 69477 Lyon Cedex 06 / FR | ||
Former [2009/32] | Tetaz, Franck Claude Edouard, et al Cabinet Régimbeau 139, rue Vendôme 69477 Lyon Cedex 06 / FR | ||
Former [2004/38] | Hubert, Philippe, et al Cabinet Beau de Loménie 158, rue de l'Université 75340 Paris Cédex 07 / FR | Application number, filing date | 02787266.2 | 18.12.2002 | [2004/38] | WO2002CA01964 | Priority number, date | CA20012365704 | 18.12.2001 Original published format: CA 2365704 | [2004/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO03051389 | Date: | 26.06.2003 | Language: | EN | [2003/26] | Type: | A2 Application without search report | No.: | EP1455814 | Date: | 15.09.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.06.2003 takes the place of the publication of the European patent application. | [2004/38] | Type: | B1 Patent specification | No.: | EP1455814 | Date: | 04.04.2012 | Language: | EN | [2012/14] | Search report(s) | International search report - published on: | EP | 12.09.2003 | Classification | IPC: | A61P3/04, A61P3/10, A61K38/27 | [2011/42] | CPC: |
A61K38/27 (EP,US);
A61P3/04 (EP);
A61P3/10 (EP)
|
Former IPC [2004/38] | A61K38/22, A61P3/04, A61P3/10 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SI, SK, TR [2004/38] | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ENTHALTEND NICHT-ACYLIERTES GHRELIN ZUR BEHANDLUNG VON INSULINRESISTENZ | [2011/42] | English: | PHARMACEUTICAL COMPOSITIONS COMPRISING UNACYLATED GHRELIN FOR USE IN THE TREATMENT OF INSULIN RESISTANCE | [2011/42] | French: | COMPOSITIONS PHARMACEUTIQUES COMPRENANT DE LA GHRELINE NON ACYLEE POUR LEUR UTILISATION DANS LE TRAITEMENT DE LA RESISTANCE A L'INSULINE | [2011/42] |
Former [2004/38] | PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ENTHALTEND NICHT-ACYLIERTES GHRELIN UND DEREN THERAPEUTISCHE VERWENDUNGEN | ||
Former [2004/38] | PHARMACEUTICAL COMPOSITIONS COMPRISING UNACYLATED GHRELIN AND THERAPEUTICAL USES THEREOF | ||
Former [2004/38] | COMPOSITIONS PHARMACEUTIQUES COMPRENANT DE LA GHRELINE NON ACYLEE ET UTILISATIONS THERAPEUTIQUES DE CES COMPOSITIONS | Entry into regional phase | 29.06.2004 | National basic fee paid | 29.06.2004 | Designation fee(s) paid | 29.06.2004 | Examination fee paid | Examination procedure | 25.06.2003 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 29.06.2004 | Examination requested [2004/38] | 30.06.2004 | Amendment by applicant (claims and/or description) | 29.09.2006 | Despatch of a communication from the examining division (Time limit: M04) | 06.02.2007 | Reply to a communication from the examining division | 07.10.2008 | Despatch of a communication from the examining division (Time limit: M06) | 16.04.2009 | Reply to a communication from the examining division | 23.07.2010 | Despatch of a communication from the examining division (Time limit: M04) | 16.11.2010 | Reply to a communication from the examining division | 30.06.2011 | Despatch of a communication from the examining division (Time limit: M04) | 24.08.2011 | Reply to a communication from the examining division | 25.10.2011 | Communication of intention to grant the patent | 20.02.2012 | Fee for grant paid | 20.02.2012 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 29.09.2006 | Opposition(s) | 07.01.2013 | No opposition filed within time limit [2013/11] | Fees paid | Renewal fee | 24.12.2004 | Renewal fee patent year 03 | 27.12.2005 | Renewal fee patent year 04 | 28.02.2007 | Renewal fee patent year 05 | 10.10.2007 | Renewal fee patent year 06 | 20.03.2008 | Renewal fee patent year 07 | 14.12.2009 | Renewal fee patent year 08 | 22.12.2010 | Renewal fee patent year 09 | 12.12.2011 | Renewal fee patent year 10 | Penalty fee | Additional fee for renewal fee | 31.12.2006 | 05   M06   Fee paid on   28.02.2007 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 04.04.2012 | BE | 04.04.2012 | CY | 04.04.2012 | CZ | 04.04.2012 | DK | 04.04.2012 | EE | 04.04.2012 | FI | 04.04.2012 | NL | 04.04.2012 | SE | 04.04.2012 | SI | 04.04.2012 | SK | 04.04.2012 | TR | 04.04.2012 | BG | 04.07.2012 | GR | 05.07.2012 | PT | 06.08.2012 | IE | 18.12.2012 | LU | 18.12.2012 | MC | 31.12.2012 | [2014/27] |
Former [2014/21] | AT | 04.04.2012 | |
BE | 04.04.2012 | ||
CY | 04.04.2012 | ||
CZ | 04.04.2012 | ||
DK | 04.04.2012 | ||
EE | 04.04.2012 | ||
FI | 04.04.2012 | ||
NL | 04.04.2012 | ||
SE | 04.04.2012 | ||
SI | 04.04.2012 | ||
SK | 04.04.2012 | ||
TR | 04.04.2012 | ||
BG | 04.07.2012 | ||
GR | 05.07.2012 | ||
PT | 06.08.2012 | ||
IE | 18.12.2012 | ||
MC | 31.12.2012 | ||
Former [2013/47] | AT | 04.04.2012 | |
BE | 04.04.2012 | ||
CY | 04.04.2012 | ||
CZ | 04.04.2012 | ||
DK | 04.04.2012 | ||
EE | 04.04.2012 | ||
FI | 04.04.2012 | ||
NL | 04.04.2012 | ||
SE | 04.04.2012 | ||
SI | 04.04.2012 | ||
SK | 04.04.2012 | ||
BG | 04.07.2012 | ||
GR | 05.07.2012 | ||
PT | 06.08.2012 | ||
IE | 18.12.2012 | ||
MC | 31.12.2012 | ||
Former [2013/34] | AT | 04.04.2012 | |
BE | 04.04.2012 | ||
CY | 04.04.2012 | ||
CZ | 04.04.2012 | ||
DK | 04.04.2012 | ||
EE | 04.04.2012 | ||
FI | 04.04.2012 | ||
NL | 04.04.2012 | ||
SE | 04.04.2012 | ||
SI | 04.04.2012 | ||
SK | 04.04.2012 | ||
BG | 04.07.2012 | ||
GR | 05.07.2012 | ||
PT | 06.08.2012 | ||
MC | 31.12.2012 | ||
Former [2013/33] | AT | 04.04.2012 | |
BE | 04.04.2012 | ||
CY | 04.04.2012 | ||
CZ | 04.04.2012 | ||
DK | 04.04.2012 | ||
EE | 04.04.2012 | ||
FI | 04.04.2012 | ||
NL | 04.04.2012 | ||
SE | 04.04.2012 | ||
SI | 04.04.2012 | ||
SK | 04.04.2012 | ||
GR | 05.07.2012 | ||
PT | 06.08.2012 | ||
MC | 31.12.2012 | ||
Former [2013/10] | AT | 04.04.2012 | |
BE | 04.04.2012 | ||
CY | 04.04.2012 | ||
CZ | 04.04.2012 | ||
DK | 04.04.2012 | ||
EE | 04.04.2012 | ||
FI | 04.04.2012 | ||
NL | 04.04.2012 | ||
SE | 04.04.2012 | ||
SI | 04.04.2012 | ||
SK | 04.04.2012 | ||
GR | 05.07.2012 | ||
PT | 06.08.2012 | ||
Former [2013/09] | AT | 04.04.2012 | |
BE | 04.04.2012 | ||
CY | 04.04.2012 | ||
DK | 04.04.2012 | ||
EE | 04.04.2012 | ||
FI | 04.04.2012 | ||
NL | 04.04.2012 | ||
SE | 04.04.2012 | ||
SI | 04.04.2012 | ||
GR | 05.07.2012 | ||
PT | 06.08.2012 | ||
Former [2013/08] | AT | 04.04.2012 | |
BE | 04.04.2012 | ||
CY | 04.04.2012 | ||
DK | 04.04.2012 | ||
FI | 04.04.2012 | ||
NL | 04.04.2012 | ||
SE | 04.04.2012 | ||
SI | 04.04.2012 | ||
GR | 05.07.2012 | ||
PT | 06.08.2012 | ||
Former [2013/07] | AT | 04.04.2012 | |
BE | 04.04.2012 | ||
CY | 04.04.2012 | ||
FI | 04.04.2012 | ||
SE | 04.04.2012 | ||
SI | 04.04.2012 | ||
GR | 05.07.2012 | ||
PT | 06.08.2012 | ||
Former [2013/04] | BE | 04.04.2012 | |
CY | 04.04.2012 | ||
FI | 04.04.2012 | ||
SE | 04.04.2012 | ||
SI | 04.04.2012 | ||
GR | 05.07.2012 | ||
PT | 06.08.2012 | ||
Former [2013/01] | CY | 04.04.2012 | |
FI | 04.04.2012 | ||
SE | 04.04.2012 | ||
SI | 04.04.2012 | ||
GR | 05.07.2012 | ||
PT | 06.08.2012 | ||
Former [2012/50] | CY | 04.04.2012 | |
FI | 04.04.2012 | ||
SE | 04.04.2012 | ||
SI | 04.04.2012 | ||
GR | 05.07.2012 | ||
Former [2012/49] | CY | 04.04.2012 | |
FI | 04.04.2012 | ||
SE | 04.04.2012 | ||
SI | 04.04.2012 | ||
Former [2012/48] | FI | 04.04.2012 | |
SE | 04.04.2012 | Cited in | International search | [AD]WO0187335 (LILLY CO ELI [US], et al) [AD] 1-57 * claims *; | [X] - CASSONI PAOLA ET AL, "Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines.", JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, (200104), vol. 86, no. 4, ISSN 0021-972X, pages 1738 - 1745, XP002243976 [X] 1,2,9,10,17-19,26,27,34,35,42,43,50,51 * page 1743, column L, paragraph 2 * * page 1744, column R, paragraph L * DOI: http://dx.doi.org/10.1210/jc.86.4.1738 | [A] - TOSHINAI KOJI ET AL, "Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (20010316), vol. 281, no. 5, ISSN 0006-291X, pages 1220 - 1225, XP002243977 [A] 1-57 * page 1224, column L, paragraph 2; figure 2 * DOI: http://dx.doi.org/10.1006/bbrc.2001.4518 | by applicant | WO0156592 | - TOSHINAI ET AL., BIOCHEMICAL AND BIOPHYSICAL COMMUNICATIONS, (2001), vol. 281, pages 1220 - 1225 |